These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17425000)

  • 1. [New targets and drugs for treatment of lipid metabolism disorders].
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):142-8. PubMed ID: 17425000
    [No Abstract]   [Full Text] [Related]  

  • 2. [New antilipemics: prospects].
    Farnier M
    Therapie; 2003; 58(1):97-105. PubMed ID: 12822207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid atherosclerosis progression and ACAT inhibition.
    Dimmitt S; Watts G
    JAMA; 2009 Jul; 302(3):255-6; author reply 256-7. PubMed ID: 19602680
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel lipid-regulating drugs.
    Thompson GR; Naoumova RP
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2619-28. PubMed ID: 11060824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid atherosclerosis progression and ACAT inhibition.
    Parini P; Eriksson M; Rudel LL
    JAMA; 2009 Jul; 302(3):255; author reply 256-7. PubMed ID: 19602681
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid-altering agents: the future.
    Wierzbicki AS
    Int J Clin Pract; 2004 Nov; 58(11):1063-72. PubMed ID: 15605675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promising therapies for cholesterol reduction.
    Brown WV
    Manag Care; 2002 Sep; 11(9 Suppl):10-4. PubMed ID: 12369337
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel agents to manage dyslipidemias and impact atherosclerosis.
    Nachimuthu S; Raggi P
    Cardiovasc Hematol Disord Drug Targets; 2006 Sep; 6(3):209-17. PubMed ID: 17017903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future.
    Hajhosseiny R; Sabir I; Khavandi K; Wierzbicki AS
    Clin Pharmacol Ther; 2014 Jul; 96(1):64-73. PubMed ID: 24699033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular pharmacology and medicinal chemistry of fibrate].
    Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel strategies for managing dyslipidemia: treatment beyond statins.
    Ling H; Burns TL; Hilleman DE
    Postgrad Med; 2012 Nov; 124(6):43-54. PubMed ID: 23322138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current drug targets for antihyperlipidemic therapy.
    Jain KS; Kulkarni RR; Jain DP
    Mini Rev Med Chem; 2010 Mar; 10(3):232-62. PubMed ID: 20105132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging strategies for the treatment of atherosclerosis as seen from the patent literature.
    Suckling KE
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):660-2. PubMed ID: 8224485
    [No Abstract]   [Full Text] [Related]  

  • 20. Reverse cholesterol transport in type 2 diabetes mellitus.
    Tan KC
    Diabetes Obes Metab; 2009 Jun; 11(6):534-43. PubMed ID: 19175378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.